Westmead Institute for Cancer Research
The Westmead Institute for Cancer Research (WICR) conducts research into the molecular and cellular basis of human cancer (breast cancer, melonoma and other skin cancers, ovarian cancer and bowel cancer) and leukaemia.
The research of WICR is focused on understanding cell growth, cell defences against cancer-causing DNA toxins, immunological defence against cancer, the relationships between viruses and cancer, and the genetic foundations of the disease.
Its researchers were a major partner in the matching and characterisation of the genes that make people susceptible to melanoma. The unit has shown new ways that hormones regulate breast cancers. The Familial cancer laboratory is one the main centres for Australian collaborative work on the genes that make women susceptible to breast cancer.
Richard Kefford is Professor of Medicine and Director of the Westmead Institute for Cancer Research in the University of Sydney at Westmead Millennium Institute, Westmead, NSW.
Research Groups
Translational Oncology
Translational Oncology is a section of cancer services formed in late 2000, which aims to facilitate the transfer of knowledge from basic cancer research into clinical practice in oncology.
The Translational Oncology research team includes postdoctoral researchers, postgraduate students and research staff and there are collaborations with clinical colleagues nationally and internationally.
The group is supported by state and national peer-reviewed grants. Current projects include studies investigating the molecular pathology of breast cancer.
Translational Oncology is also involved in the management and operation of a state-wide breast cancer tumour bank supporting tissue based cancer research. |
Annual Reports
To view these reports you require Adobe Acrobat Reader.

|